Luca LD, et al. - In a cohort of patients with stable coronary artery disease, authors ascertained the prevalence and pharmacologic management of familial hypercholesterolemia (FH), an inherited disorder characterized by elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) associated with premature cardiovascular disease. Data from the START (STable Coronary Artery Diseases RegisTry) study, a nationwide, prospective survey on patients with stable coronary artery disease, was used for this analysis. FH was highly prevalent and generally undertreated with lipid-lowering therapies in patients in this large cohort.